Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

RGEN

Repligen (RGEN)

Repligen Corp
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RGEN
日付受信時刻ニュースソース見出しコード企業名
2024/09/1905 : 21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
2024/09/1300 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/09/1105 : 03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
2024/09/0509 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/09/0508 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/08/2320 : 30GlobeNewswire Inc.Repligen Corporation to Present at Wells Fargo Healthcare ConferenceNASDAQ:RGENRepligen Corp
2024/08/2008 : 29Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RGENRepligen Corp
2024/08/0610 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/08/0304 : 26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
2024/08/0209 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/08/0206 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/08/0205 : 11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
2024/08/0205 : 07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
2024/07/3106 : 04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RGENRepligen Corp
2024/07/3020 : 46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
2024/07/3020 : 30GlobeNewswire Inc.Repligen Reports Second Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
2024/07/3005 : 00GlobeNewswire Inc.Repligen Announces Agreement to Acquire Chromatography Innovator TanttiNASDAQ:RGENRepligen Corp
2024/07/1620 : 30GlobeNewswire Inc.Repligen to Report Second Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
2024/07/1605 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
2024/06/1507 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/06/1506 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/06/1506 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/06/1506 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/06/1506 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
2024/06/1320 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
2024/06/1320 : 00GlobeNewswire Inc.Repligen Announces CEO Transition PlanNASDAQ:RGENRepligen Corp
2024/05/2306 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
2024/05/2220 : 30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming June Investor ConferencesNASDAQ:RGENRepligen Corp
2024/05/2205 : 09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
2024/05/2108 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
 Showing the most relevant articles for your search:NASDAQ:RGEN